A Clinical Study of HT-101 and HT-102 in Patients With Chronic Hepatitis B Virus Infection
Clinical trial NCT07245953 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07245953
- Sponsor
- Suzhou HepaThera Biotech Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-05
- Primary completion
- 2027-02-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.